Lucigen is working to improve people’s lives by providing quality biomedical products and services used across the spectrum from basic research to molecular diagnostics. We manufacture and sell over 325 biomedical research products to life-science and healthcare professionals worldwide. Lucigen leverages its expertise in enzyme evolution and core competencies that support a variety of applications such as synthetic biology, next gen sequencing, and human diagnostics. Lucigen’s acquisition of Epicentre products expanded our portfolio offering into array-based analysis, in vitro transcription, nucleic-acid extraction purification, and transposon mutagenesis. As an ISO 13485-certified company, we proudly offer catalog and custom solutions to meet researchers’ expanding needs, including OEM partnerships.
Location: United States, Wisconsin, Middleton
Employees: 51-200
Founded date: 1998
Investors 2
| Date | Name | Website |
| - | Central Il... | centralill... |
| - | Silicon Pa... | siliconpas... |
Mentions in press and media 1
| Date | Title | Description |
| 03.09.2024 | Next Generation Sequencing Market is poised to grow from USD 36.04 billion by 2031: Skyquest Technology | Share Tweet Share Share Email In recent years, next generation sequencing is a technique that employs massive parallelism in sequencing millions or even billions of DNA strands. This method is also known as high throughput sequencing. NGS i... |